<p>Oscar Health, Inc. (NYSE:OSCR - 獲取免費報告) 在週一的午盤交易中創下了新的 52 周高點。該股最高交易價格為 26.06 美元，最後交易價格為 26.5660 美元，成交量為 1727899 股。該股此前收盤價為 24.51 美元。</p>
<h2>華爾街分析師預測增長</h2>
<ul>
<li>5 只具有爆炸性上漲潛力的小型股</li>
</ul>
<p>多家研究分析師最近對 OSCR 股票發佈了報告。傑富瑞金融集團將 Oscar Health 的評級從 “表現不佳” 上調至 “持有”，並在 4 月 20 日的報告中將該公司的目標價從 10.00 美元上調至 16.00 美元。華爾街 Zen 在週六的研究報告中將 Oscar Health 的評級從 “強力買入” 下調至 “買入”。雷蒙德·詹姆斯金融公司在 2 月 12 日的研究報告中將 Oscar Health 的評級從 “市場表現” 上調至 “跑贏大盤”，並設定了 18.00 美元的目標價。富國銀行在週四的報告中對 Oscar Health 的股票設定了 20.00 美元的目標價，並給予該股 “等權重” 評級。最後，巴克萊在 5 月 26 日的報告中將 Oscar Health 的目標價從 21.00 美元上調至 30.00 美元，並給予該公司 “等權重” 評級。一位研究分析師對該股給予了強力買入評級，兩位給予了買入評級，八位給予了持有評級，一位給予了賣出評級。根據 MarketBeat.com 的數據，該公司目前的平均評級為 “持有”，平均目標價為 20.22 美元。</p>
<p><strong>閲讀我們關於 OSCR 的最新股票報告</strong></p>
<h2>Oscar Health 價格表現</h2>
<p>該股的 50 日移動平均價格為 18.39 美元，200 日移動平均價格為 16.07 美元。該公司的流動比率為 1.11，速動比率為 1.11，債務與股本比率為 0.26。該股的市值為 79.2 億美元，市盈率為-44.70，PEG 比率為 1.71，貝塔值為 2.37。</p>
<p>Oscar Health (NYSE:OSCR - 獲取免費報告) 最近在 5 月 6 日發佈了季度財報。該公司報告每股收益為 2.07 美元，超出市場共識預期的 1.11 美元，超出幅度為 0.96 美元。Oscar Health 的股本回報率為-3.26%，淨利潤率為-0.30%。該業務在本季度的收入為 46.5 億美元，而市場共識預期為 49 億美元。去年同期，該公司每股收益為 0.92 美元。該公司的季度收入同比增長 52.6%。整體來看，股票研究分析師預測 Oscar Health, Inc.在本年度將發佈 0.47 美元的每股收益。</p>
<h2>內部活動</h2>
<p>在其他 Oscar Health 的新聞中，內部人士 Janet Liang 在 6 月 2 日的交易中出售了 12475 股該公司的股票。股票以平均價格 21.94 美元出售，總交易額為 273,701.50 美元。交易完成後，內部人士直接持有該公司 259,057 股股票，價值約為 5,683,710.58 美元。此交易代表其持股比例下降了 4.59%。該交易已在 SEC 的備案中披露，可以通過此鏈接訪問。該交易是在預先安排的 10b5-1 交易計劃下執行的。出售是為了覆蓋與股權獎勵歸屬相關的税收扣繳義務。此外，首席會計官 Victoria Baltrus 在 6 月 2 日的交易中出售了 1523 股 Oscar Health 股票。股票以平均價格 21.94 美元出售，總交易額為 33,414.62 美元。出售後，首席會計官持有該公司 214,589 股股票，價值約為 4,708,082.66 美元。該交易代表其持股比例下降了 0.70%。該出售的披露信息可在 SEC 備案中找到。該交易是在預先安排的 10b5-1 交易計劃下執行的。出售是為了覆蓋與股權獎勵歸屬相關的税收扣繳義務。在過去的 90 天裏，內部人士出售了 189,660 股公司股票，價值為 4,283,140 美元。25.11% 的股票由公司內部人士持有。</p>
<h2>機構資金流入和流出</h2>
<p>多家機構投資者和對沖基金最近增加或減少了對該公司的持股。Thrive Capital Management LLC 在第四季度將其在 Oscar Health 的持股增加了 33.4%。Thrive Capital Management LLC 目前持有 6,343,617 股該公司的股票，價值為 85,258,000 美元，此前在上個季度又購買了 1,588,395 股。Baird Financial Group Inc.在第一季度購買了 Oscar Health 的新頭寸，價值約為 159,000 美元。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.在第一季度將其在 Oscar Health 的持股增加了 4.3%。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.目前持有 215,650 股該公司的股票，價值為 2,827,000 美元，此前在該期間又收購了 8,879 股。Jones Financial Companies Lllp 在第一季度將其在 Oscar Health 的持股增加了 7,473.3%。Jones Financial Companies Lllp 目前持有 2,272 股該公司的股票，價值為 30,000 美元，此前在上個季度又購買了 2,242 股。最後，瑞銀資產管理美洲有限公司的一個獨特業務單位在第一季度將其在 Oscar Health 的持股增加了 39.0%。瑞銀資產管理美洲有限公司的一個獨特業務單位目前持有 470,590 股該公司的股票，價值為 6,169,000 美元，此前在上個季度又購買了 132,149 股。75.70% 的股票目前由機構投資者和對沖基金持有。</p>
<h2>關於 Oscar Health</h2>
<p>(獲取免費報告)</p>
<p>Oscar Health，作為紐約證券交易所上市公司，股票代碼為 OSCR，是一家總部位於紐約的科技驅動健康保險公司。該公司由 Mario Schlosser、Joshua Kushner 和 Kevin Nazemi 於 2012 年創立，旨在簡化醫療保險覆蓋並提升會員體驗。Oscar 利用其專有的數字平台來簡化計劃註冊、索賠管理和會員支持，在個人、家庭和小型團體保險市場中脱穎而出。</p>
<p>公司的主要產品包括根據《平價醫療法案》提供的交易所內個人和家庭醫療計劃、交易所外計劃以及醫療保險優勢產品。</p>
<h2>精選文章</h2>
<ul>
<li>五隻我們認為比 Oscar Health 更好的股票</li>
<li>Macy's 的表現如何：伯克希爾哈撒韋最新的購買</li>
<li>Planet Labs：迴歸現實</li>
<li>Docusign：又一次超預期，又一次拋售——分析師為何錯了</li>
<li>Meta 推出訂閲服務：具有真正增長潛力的新產品</li>
</ul>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。如對本故事有任何問題或意見，請發送郵件至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1000 美元在 Oscar Health 嗎？</h2>
<p>在考慮 Oscar Health 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Oscar Health 並不在名單上。</p>
<p>儘管 Oscar Health 目前在分析師中獲得了持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

OSCR

OSCG

OSCX

<p>Oscar Health（紐約證券交易所代碼：OSCR）達到了新的 52 周高點 26.06 美元，主要受到近期分析師升級和積極的盈利意外的推動。儘管公司每股收益（EPS）為 2.07 美元，超出預期，但收入未能達到預測。儘管內部人士因税務義務進行了出售，但像 Thrive Capital 這樣的機構投資者增加了他們的持股。分析師維持平均 “持有” 評級，目標價共識為 20.22 美元</p>

<p>Oscar Health, Inc. (NYSE:OSCR - Get Free Report) hit a new 52-week high during mid-day trading on Monday . The stock traded as high as $26.06 and last traded at $26.5660, with a volume of 1727899 shares changing hands. The stock had previously closed at $24.51.</p>
<div class="lb-trans"><p>Oscar Health, Inc. (NYSE:OSCR - 獲取免費報告) 在週一的午盤交易中創下了新的 52 周高點。該股最高交易價格為 26.06 美元，最後交易價格為 26.5660 美元，成交量為 1727899 股。該股此前收盤價為 24.51 美元。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>華爾街分析師預測增長</h2>
</div><ul>
<li>5 Small Cap Stocks With Explosive Upside Potential</li>
</ul>
<div class="lb-trans"><ul>
<li>5 只具有爆炸性上漲潛力的小型股</li>
</ul>
</div><p>A number of research analysts have recently issued reports on OSCR shares. Jefferies Financial Group upgraded Oscar Health from an &#34;underperform&#34; rating to a &#34;hold&#34; rating and lifted their price target for the company from $10.00 to $16.00 in a report on Monday, April 20th. Wall Street Zen downgraded Oscar Health from a &#34;strong-buy&#34; rating to a &#34;buy&#34; rating in a research report on Saturday. Raymond James Financial upgraded Oscar Health from a &#34;market perform&#34; rating to an &#34;outperform&#34; rating and set a $18.00 target price on the stock in a research note on Thursday, February 12th. Wells Fargo &amp; Company set a $20.00 target price on shares of Oscar Health and gave the stock an &#34;equal weight&#34; rating in a report on Thursday. Finally, Barclays raised their price target on shares of Oscar Health from $21.00 to $30.00 and gave the company an &#34;equal weight&#34; rating in a report on Tuesday, May 26th. One research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of &#34;Hold&#34; and an average price target of $20.22.</p>
<div class="lb-trans"><p>多家研究分析師最近對 OSCR 股票發佈了報告。傑富瑞金融集團將 Oscar Health 的評級從 “表現不佳” 上調至 “持有”，並在 4 月 20 日的報告中將該公司的目標價從 10.00 美元上調至 16.00 美元。華爾街 Zen 在週六的研究報告中將 Oscar Health 的評級從 “強力買入” 下調至 “買入”。雷蒙德·詹姆斯金融公司在 2 月 12 日的研究報告中將 Oscar Health 的評級從 “市場表現” 上調至 “跑贏大盤”，並設定了 18.00 美元的目標價。富國銀行在週四的報告中對 Oscar Health 的股票設定了 20.00 美元的目標價，並給予該股 “等權重” 評級。最後，巴克萊在 5 月 26 日的報告中將 Oscar Health 的目標價從 21.00 美元上調至 30.00 美元，並給予該公司 “等權重” 評級。一位研究分析師對該股給予了強力買入評級，兩位給予了買入評級，八位給予了持有評級，一位給予了賣出評級。根據 MarketBeat.com 的數據，該公司目前的平均評級為 “持有”，平均目標價為 20.22 美元。</p>
</div><p><strong>Read Our Latest Stock Report on OSCR</strong></p>
<div class="lb-trans"><p><strong>閲讀我們關於 OSCR 的最新股票報告</strong></p>
</div><h2>Oscar Health Price Performance</h2>
<div class="lb-trans"><h2>Oscar Health 價格表現</h2>
</div><p>The stock has a 50-day moving average price of $18.39 and a two-hundred day moving average price of $16.07. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.26. The stock has a market cap of $7.92 billion, a price-to-earnings ratio of -44.70, a PEG ratio of 1.71 and a beta of 2.37.</p>
<div class="lb-trans"><p>該股的 50 日移動平均價格為 18.39 美元，200 日移動平均價格為 16.07 美元。該公司的流動比率為 1.11，速動比率為 1.11，債務與股本比率為 0.26。該股的市值為 79.2 億美元，市盈率為-44.70，PEG 比率為 1.71，貝塔值為 2.37。</p>
</div><p>Oscar Health (NYSE:OSCR - Get Free Report) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $2.07 earnings per share for the quarter, topping the consensus estimate of $1.11 by $0.96. Oscar Health had a negative return on equity of 3.26% and a negative net margin of 0.30%.The business had revenue of $4.65 billion during the quarter, compared to the consensus estimate of $4.90 billion. During the same quarter last year, the company earned $0.92 earnings per share. The company's quarterly revenue was up 52.6% on a year-over-year basis. As a group, equities research analysts forecast that Oscar Health, Inc. will post 0.47 EPS for the current year.</p>
<div class="lb-trans"><p>Oscar Health (NYSE:OSCR - 獲取免費報告) 最近在 5 月 6 日發佈了季度財報。該公司報告每股收益為 2.07 美元，超出市場共識預期的 1.11 美元，超出幅度為 0.96 美元。Oscar Health 的股本回報率為-3.26%，淨利潤率為-0.30%。該業務在本季度的收入為 46.5 億美元，而市場共識預期為 49 億美元。去年同期，該公司每股收益為 0.92 美元。該公司的季度收入同比增長 52.6%。整體來看，股票研究分析師預測 Oscar Health, Inc.在本年度將發佈 0.47 美元的每股收益。</p>
</div><h2>Insider Activity</h2>
<div class="lb-trans"><h2>內部活動</h2>
</div><p>In other Oscar Health news, insider Janet Liang sold 12,475 shares of the firm's stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $21.94, for a total transaction of $273,701.50. Following the completion of the transaction, the insider directly owned 259,057 shares of the company's stock, valued at approximately $5,683,710.58. This trade represents a 4.59% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CAO Victoria Baltrus sold 1,523 shares of Oscar Health stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $21.94, for a total transaction of $33,414.62. Following the sale, the chief accounting officer owned 214,589 shares of the company's stock, valued at approximately $4,708,082.66. The trade was a 0.70% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last ninety days, insiders sold 189,660 shares of company stock valued at $4,283,140. 25.11% of the stock is owned by corporate insiders.</p>
<div class="lb-trans"><p>在其他 Oscar Health 的新聞中，內部人士 Janet Liang 在 6 月 2 日的交易中出售了 12475 股該公司的股票。股票以平均價格 21.94 美元出售，總交易額為 273,701.50 美元。交易完成後，內部人士直接持有該公司 259,057 股股票，價值約為 5,683,710.58 美元。此交易代表其持股比例下降了 4.59%。該交易已在 SEC 的備案中披露，可以通過此鏈接訪問。該交易是在預先安排的 10b5-1 交易計劃下執行的。出售是為了覆蓋與股權獎勵歸屬相關的税收扣繳義務。此外，首席會計官 Victoria Baltrus 在 6 月 2 日的交易中出售了 1523 股 Oscar Health 股票。股票以平均價格 21.94 美元出售，總交易額為 33,414.62 美元。出售後，首席會計官持有該公司 214,589 股股票，價值約為 4,708,082.66 美元。該交易代表其持股比例下降了 0.70%。該出售的披露信息可在 SEC 備案中找到。該交易是在預先安排的 10b5-1 交易計劃下執行的。出售是為了覆蓋與股權獎勵歸屬相關的税收扣繳義務。在過去的 90 天裏，內部人士出售了 189,660 股公司股票，價值為 4,283,140 美元。25.11% 的股票由公司內部人士持有。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>機構資金流入和流出</h2>
</div><p>A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Thrive Capital Management LLC boosted its stake in shares of Oscar Health by 33.4% in the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company's stock worth $85,258,000 after buying an additional 1,588,395 shares during the last quarter. Baird Financial Group Inc. purchased a new position in Oscar Health during the first quarter valued at approximately $159,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Oscar Health by 4.3% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 215,650 shares of the company's stock valued at $2,827,000 after acquiring an additional 8,879 shares during the period. Jones Financial Companies Lllp boosted its position in Oscar Health by 7,473.3% in the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company's stock worth $30,000 after purchasing an additional 2,242 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in Oscar Health by 39.0% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 470,590 shares of the company's stock worth $6,169,000 after purchasing an additional 132,149 shares in the last quarter. 75.70% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>多家機構投資者和對沖基金最近增加或減少了對該公司的持股。Thrive Capital Management LLC 在第四季度將其在 Oscar Health 的持股增加了 33.4%。Thrive Capital Management LLC 目前持有 6,343,617 股該公司的股票，價值為 85,258,000 美元，此前在上個季度又購買了 1,588,395 股。Baird Financial Group Inc.在第一季度購買了 Oscar Health 的新頭寸，價值約為 159,000 美元。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.在第一季度將其在 Oscar Health 的持股增加了 4.3%。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.目前持有 215,650 股該公司的股票，價值為 2,827,000 美元，此前在該期間又收購了 8,879 股。Jones Financial Companies Lllp 在第一季度將其在 Oscar Health 的持股增加了 7,473.3%。Jones Financial Companies Lllp 目前持有 2,272 股該公司的股票，價值為 30,000 美元，此前在上個季度又購買了 2,242 股。最後，瑞銀資產管理美洲有限公司的一個獨特業務單位在第一季度將其在 Oscar Health 的持股增加了 39.0%。瑞銀資產管理美洲有限公司的一個獨特業務單位目前持有 470,590 股該公司的股票，價值為 6,169,000 美元，此前在上個季度又購買了 132,149 股。75.70% 的股票目前由機構投資者和對沖基金持有。</p>
</div><h2>About Oscar Health</h2>
<div class="lb-trans"><h2>關於 Oscar Health</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(獲取免費報告)</p>
</div><p>Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.</p>
<div class="lb-trans"><p>Oscar Health，作為紐約證券交易所上市公司，股票代碼為 OSCR，是一家總部位於紐約的科技驅動健康保險公司。該公司由 Mario Schlosser、Joshua Kushner 和 Kevin Nazemi 於 2012 年創立，旨在簡化醫療保險覆蓋並提升會員體驗。Oscar 利用其專有的數字平台來簡化計劃註冊、索賠管理和會員支持，在個人、家庭和小型團體保險市場中脱穎而出。</p>
</div><p>The company's primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.</p>
<div class="lb-trans"><p>公司的主要產品包括根據《平價醫療法案》提供的交易所內個人和家庭醫療計劃、交易所外計劃以及醫療保險優勢產品。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精選文章</h2>
</div><ul>
<li>Five stocks we like better than Oscar Health</li>
<li>What's Make of Macy's: Berkshire Hathaway's Latest Buy</li>
<li>Planet Labs: Coming Back Down to Earth</li>
<li>Docusign: Another Beat, Another Selloff—Why the Analysts Are Wrong</li>
<li>Meta Unveils Subscriptions: A New Offering With Real Growth Potential</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們認為比 Oscar Health 更好的股票</li>
<li>Macy's 的表現如何：伯克希爾哈撒韋最新的購買</li>
<li>Planet Labs：迴歸現實</li>
<li>Docusign：又一次超預期，又一次拋售——分析師為何錯了</li>
<li>Meta 推出訂閲服務：具有真正增長潛力的新產品</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。如對本故事有任何問題或意見，請發送郵件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Oscar Health Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1000 美元在 Oscar Health 嗎？</h2>
</div><p>Before you consider Oscar Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Oscar Health 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Oscar Health 並不在名單上。</p>
</div><p>While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>儘管 Oscar Health 目前在分析師中獲得了持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Oscar Health（NYSE:OSCR）創下 52 周新高 - 以下是原因